Back

The need for diuretic therapy in spite of heart failure with reduced ejection fraction foundational therapy: a new marker of adverse prognosis?

22 May 2022 (08:30 - 19:45)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Acute Heart Failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Ana Beatriz Garcia

CHULN and Faculty of medicine of the University of Lisbon, Lisbon (Portugal)

25 More presentations in this session

Presentation thumbnail
Higher inpatient mortality in heart failure hospitalizations with comorbid cancer
Doctor G. Greenberg (New York City, US)
Abstract Slides
Presentation thumbnail
Comparison of risk scores: prediction of outcome of in-hospital mortality for acute heart failure
Doctor J. Correia (Viseu, PT)
Abstract Slides
Presentation thumbnail
Systolic blood pressure at admission in patients hospitalized for heart failure: long-term outcomes
Doctor V. Lopes (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Age-stratified utility of NT-proBNP testing as part of a blind Emergency Department shortness of breath orderset (Jan-Dec 2019)
Doctor M. Peterzan (London, GB)
Abstract Slides
Presentation thumbnail
Validation of a novel device for noninvasive assessment of central venous pressure with potential in acute heart failure prevention: preliminary experience
Doctor G. Casu (Sassari, IT)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Acute Heart Failure

The Event

Event poster

Heart Failure 2022

22 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources